Tianjing Ren

Tianjing Ren is a Principal Scientist in Clinical Pharmacology at EMD Serono, Inc. since November 2023, following a role as a UB/GSK Postdoctoral Fellow at GSK from October 2021 to October 2023, where the focus was on developing a mechanistic QSP model for chronic hepatitis B virus infection and evaluating renal function estimation equations. Prior experience includes a Postdoctoral Research Associate position at the State University of New York at Buffalo, specializing in metabolomic analysis and pharmacokinetics of gamma-hydroxybutyric acid. Early career training involved internships at TWGHs Wong Tai Sin Hospital and Guangdong Province Traditional Chinese Medical Hospital, providing experience in Chinese Medicine. Tianjing holds a PhD in Pharmacy from The Chinese University of Hong Kong and a Bachelor's degree in Pharmacy with Honors from Hong Kong Baptist University.